Mobile site
|
Doctors Signup
|
Login
|
Register
Swap Transplant
Healthcare provider
Find Doctors
Find Hospitals
Find Diagnostic Labs
Find Disability Help Org.
Disease management
Disease List
Surgical Procedures
Diagnostic Tests
Post a Query
Ehr
Offers
My discussion
Consult a doctor
Community
Hope blog
Doctor-Speak
Patient Story
Wellness
If you are looking for any ongoing clinical trials, try our "
Clinical Research Search
"
List of "
Diabetology
" clinical trials
CTRI/2009/091/000598
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
CTRI/2010/091/006110
A 12-WEEK STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETIC AND EFFECT ON GLYCEMIC CONTROL OF P1736-05 IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS
CTRI/2010/091/000063
A 2-year, clinical Trial to Evaluate the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy.
CTRI/2010/091/001158
A clinical study on type II diabetes patients.
CTRI/2010/091/000424
A clinical study on type II diabetic patients.
CTRI/2008/091/000226
A clinical study to compare effects and safety Of recombinant Insulin Glargine manufactured by Biocon Ltd Compared to marketed Glargine (Lantus) In patients of Type 1 Diabetes Mellitus.
CTRI/2008/091/000206
A clinical study to evaluate effect of surgery for control of Type2 diabetes in overweight individuals
CTRI/2008/091/000180
A clinical study to evaluate the effects of GLP-1 agonist AVE0010 in patients with type 2 diabetes mellitus for Glycemic control and safety evaluation, on top of basal insulin.
CTRI/2008/091/000176
A clinical study to evaluate the effects of GLP-1 agonist AVE0010 in patients with type 2 diabetes mellitus for Glycemic control and safety evaluation, on top of Sulfonylurea
CTRI/2010/091/000684
A clinical study to evaluate the safety, tolerability and pharmacokinetics of ZYOG1 following oral administration in healthy volunteers.
CTRI/2009/091/000862
A clinical trial Comparing the immunogenicity of two different brands of human Insulin for the treatment of diabetes.
CTRI/2010/091/003059
A clinical trial of Sleeve Gastrectomy With Ileal interposition for Control of Type 2 Diabetes
CTRI/2010/091/001479
A clinical trial study to evaluate the efficacy and safety of Epalrestat 150 mg Sustained Release Tablets in patients suffering from (peripheral) diabetic neuropathy
CTRI/2010/091/000012
A clinical trial to assess the efficacy and safety of recombinant insulin glargine compared with Lantus® in patients with Type II Diabetes Mellitus uncontrolled on OAD Therapy.
CTRI/2009/091/000528
A clinical trial to compare effect of Travoprost APS to TRAVATAN in patients with open-angle glaucoma or ocular hypertension
CTRI/2009/091/000125
A clinical Trial to compare the effects and safety of different combinations of the trial drug and metformin over 24 weeks in drug naïve or previously treated (after with holding the treatment for 4 weeks) type 2 diabetic patients with poor control of blood sugar levels.
CTRI/2009/091/000824
A clinical Trial to compare the effects and safety of linagliptin 2.5 mg twice daily dose vs linagliptin 5 mg once daily dose for 12 weeks with background therapy of metformin, in subjects who are not exposed to linagliptin or previously treated with other oral hypoglycemic drugs(after with holding the treatment for 4weeks) in patients with type 2 diabetes mellitus and insufficient blood glucose control
CTRI/2010/091/001091
A clinical trial to determine the effect of Reflexology therapy in addition to the pharmacological drugs for managing patients suffering from Diabetic Neuropathy
CTRI/2009/091/000457
A Clinical Trial to evaluate Glucose-Dependant Insulinotropic Effects of Single dose of a DPP-4 inhibitor
CTRI/2010/091/000353
A clinical trial to evaluate the efficacy and safety of LC15 - 0444 in patients with type II diabetes.
CTRI/2010/091/000078
A Clinical trial to evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background therapy with glimepiride with or without metformin.
CTRI/2010/091/000098
A Clinical trial to evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background therapy with pioglitazone.
CTRI/2009/091/000038
A clinical trial to evaluate the safety and efficacy of MBX-102/JNJ-39659100 in patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Monotherapy
CTRI/2009/091/000513
A clinical trial to evaluate the safety and efficacy of ReliDerm®DT in patients of non healing diabetic foot ulcer
CTRI/2008/091/000053
A clinical trial to study activity and safety of Ayurvedic formulation containing Ashwagadha and Haridra in patients freshly diagnosed with Type 2 Diabetes mellitus
CTRI/2010/091/001036
A clinical trial to study and compare the effects of two drugs amitriptyline and duloxetine in patients with type 2 diabetes mellitus with neuropathic pain
CTRI/2010/091/000516
A clinical trial to study reduction of cardiovascular mortality and morbidity in Type 2 diabetes mellitus patients with a recent Acutecoronarysyndrome event.
CTRI/2008/091/000054
A clinical trial to study safety and activity of Ayurvedic formulation containing Ashwagandha and Haridra in patients with Type 2 Diabetes mellitus receiving oral anti-diabetic agents
CTRI/2009/091/000098
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.
CTRI/2010/091/000627
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.
CTRI/2008/091/000276
A clinical trial to study the blood sugar lowering effects and safety of oral insulin (IN-105 tablets) in patients of type 2 Diabetes Mellitus.
CTRI/2010/091/001415
A clinical trial to study the effect of Desmopressin Intranasal Solution BP (Mfd. by Biodeal Laboratories Pvt. Ltd.) Vs. Desmopressin Intranasal Solution BP (Mfd. by Ferring Pharmaceuticals Ltd.) in patients diagnosed with Central Cranial Diabetes Insipidus.
CTRI/2009/091/001036
A clinical trial to study the effect of hydroxychloroquine in comparison with pioglitazone in the treatment of type II diabetes mellitus
CTRI/2009/091/000702
A Clinical trial to study the effects of a unani formulation Diabeat in patients with high blood sugar levels (Type 2 diabetes mellitus )
CTRI/2009/091/000663
A clinical trial to study the effects of Dutogliptin in patients with type 2 diabetes mellitus.
CTRI/2011/091/000266
A clinical trial to study the effects of fixed dose combination of Glimepiride + Metformin SR + Pioglitazone vs Fixed dose combination of Glimepiride + Metformin SR in treatment of patients with type 2 diabetes inadequately controlled with monotherapy of either glimepiride or metformin plain/SR formulation
CTRI/2009/091/001081
A clinical trial to study the effects of Linagliptin in patients with type 2 diabetes mellitus despite taking metformin therapy in combination with pioglitazone.
CTRI/2009/091/000632
A clinical trial to study the effects of Naturlose (Tagatose) in patients with mild type 2 Diabetes Mellitus under control with Diet and Exercise over a period of 6 months
CTRI/2010/091/000188
A clinical trial to study the effects of seven sequences of Pranayama and oral hypoglycemic drugs versus only oral hypoglycemic drugs in type 2 diabetes mellitus.
CTRI/2009/091/000714
A clinical trial to study the effects of two drugs,metformin and Alpha Lipoic Acid combination in patients of Diabetic polyneuropathy.
CTRI/2008/091/000071
A clinical trial to study the efficacy and safety of AVE0010 in patients with type 2 diabetes not treated with antidiabetic agents
CTRI/2010/091/001458
A clinical trial to study the efficacy and safety of topical gel containing fixed dose combination of Amitriptyline, Lidocaine and Capsaicin in treatment of neurogenic pain associated with localized peripheral neuropathies.
CTRI/2009/091/000729
A clinical trial to study the long term effects of Teplizumab in Children and Adults with Recent-Onset Type 1 Diabetes Mellitus
CTRI/2010/091/000500
A clinical trial to study the long-term safety of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin.
CTRI/2010/091/000040
A clinical trial to study the requirement of isoflurane and vecuronium in diabetic patients with and without diabetic autonomic neuropathy undergoing elective surgery; as determined by entropy and NMT monitor respectively- A prospective double blind study.
CTRI/2010/091/000275
A clinical trial to study the safety and effects of new chemical molecule ADV-1002401 in Healthy, Adult Volunteers and Adult Type-II Diabetic Volunteers.
CTRI/2009/091/000533
A clinical trial to study the safety and efficacy of 2mg and 4mg of ZYH1 compared to placebo in hypertriglyceridemia with type II diabetes not controlled with Atorvastatin therapy.
CTRI/2010/091/000162
A clinical trial to study the side effects of a drug, MBX-2982 and also to study how well it works and is tolerated when compared to a placebo and a comparator in patients with Type 2 Diabetes Mellitus.
CTRI/2009/091/000688
A comparative evaluation of efficacy, safety & tolerability of Amitriptyline 4% + Ketamine 2% Cream, with Capsaicin Cream 0.025%, in adult patients suffering from Neuralgia due to diabetes, chemotherapy or shingles.
CTRI/2010/091/001473
A comparative study to evaluate the two formulations of ZYO1 in healthy volunteers
CTRI/2009/091/000210
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
CTRI/2009/091/000200
A comparison of various antioxidant preparations on insulin sensitivity in Type 2 diabetes patients
CTRI/2010/091/000364
A multi-national clinical trial to evaluate the efficacy and safety of LC15-0444 ;as compared to sitagliptin added to ongoing metformin therapy in patients with Type II diabetes inadequately controlled with metformin alone.
CTRI/2010/091/001185
A multi-site, individually randomized, controlled translation trial of integrated and comprehensive care strategies to reduce CVD risk among 1,120 T2DM patients in South Asia.
CTRI/2009/091/000121
A Multicenter Trial to Evaluate the Efficacy and Safety of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
CTRI/2009/091/000100
A Multicenter, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin 10 mg in Combination with Metformin as Initial Therapy as Compared with Dapagliflozin 10 mg and Metformin Monotherapy in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control.
CTRI/2008/091/000186
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Thiazolidinedione Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Thiazolidinedione Therapy Alone
CTRI/2009/091/000174
A Multicenter, Randomized,Placebo Controlled,Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
CTRI/2009/091/000578
A Multicenteric clinical study to compare Brinzolamide 1% Ophthalmic Suspension with Dorzox (Dorzolamide) 2% Ophthalmic Solution in treatment of Elevated Intra-Ocular Pressure in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
CTRI/2009/091/000043
A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with type 2 diabetes mellitus receiving oral anti-diabetic drug with or without insulin.
CTRI/2009/091/000614
A Phase IIa, Multicenter, Randomized, Placebo- and Active- Comparator Controlled, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
CTRI/2010/091/000528
A Phase III Randomized Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin 100 mg in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on a Sulfonylurea in Combination With Metformin.
CTRI/2010/091/000430
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone. The purpose of this clinical research study is to learn if BMS-512148 (Dapagliflozin) can help reduce the blood sugar levels in Asian patients with Type 2 Diabetes who are not well controlled on metformin alone. The safety of this treatment will also be studied.
CTRI/2010/091/000429
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
CTRI/2010/091/001280
A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India (Lead-In)
CTRI/2009/091/000104
A randomized double blind active controlled parallel clinical trial to compare the effect of exercises(yogic/walking) on serum insulin level and glycemic control in patients with type 2 diabetes with high and low serum insulin values.
CTRI/2009/091/000947
A Randomized, Double-Blind, Placebo- and Sitagliptin-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment Including Subjects on Hemodialysis
CTRI/2009/091/000807
A randomized, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week double-blind treatment period assessing the efficacy and safety of lixisenatide in patients with Type 2 diabetes insufficiently controlled with insulin glargine and metformin.
CTRI/2009/091/000091
A Study for Patients With Type 2 Diabetes Mellitus
CTRI/2010/091/000300
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-2).
CTRI/2010/091/003036
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
CTRI/2010/091/002828
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
CTRI/2009/091/000969
A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin
CTRI/2010/091/000160
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease.
CTRI/2010/091/001444
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
CTRI/2010/091/001494
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
CTRI/2009/091/000154
A Study to Compare MK-0941 and Glimepiride in Patients with Type 2 Diabetes on Metformin
CTRI/2009/091/000412
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and a Thiazolidinedione in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
CTRI/2010/091/001238
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
CTRI/2010/091/000071
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine.
CTRI/2009/091/000485
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
CTRI/2010/091/000343
A study to evaluate the effect of ASP 1941 in adult patients with type 2 diabetes mellitus.
CTRI/2010/091/000389
A STUDY TO EVALUATE THE EFFECT OF EDIBLE OIL IN PATIENTS OF TYPE II DIABETES MELLITUS & HYPERTENSION.
CTRI/2010/091/001110
A study to Evaluate the Efficacy and Safety of Saxagliptin in Combination with Metformin and Sulfonylurea in Subjects with Type 2 Diabetes
CTRI/2009/091/000608
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
CTRI/2008/091/000031
A trial in type 2 diabetes comparing NN9535 to placebo and liraglutide
CTRI/2010/091/001302
A trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients With Type 2 Diabetes
CTRI/2008/091/000001
ALiskiren Trial In Type 2 diabetes Using cardiorenal Disease Endpoints
CTRI/2010/091/000223
Comparative clinical trial of combination of Epalrestat 50 mg + Methylcobalamin 500 mcg with Epalrestat in the treatment of Diabetic neuropathy.
CTRI/2010/091/000623
Comparing safety and efficacy of NN5401 with insulin glargine in subjects with type 2 diabetes: An extension to trial NN5401-3590
CTRI/2010/091/000145
Comparison of NN1250 plus insulin Aspart with insulin Detemir plus insulin Aspart in type 1 diabetes.
CTRI/2010/091/001097
Comparison of NN1250 plus insulin aspart with insulin detemir plus insulin aspart in type 1 diabetes: An extension trial to NN1250-3585
CTRI/2010/091/000024
Comparison of NN1250 with sitagliptin in subjects with type 2 diabetes never treated with insulin.
CTRI/2010/091/000044
Comparison of NN5401 versus insulin glargine, both with metformin treatment, in subjects with type 2 diabetes.
CTRI/2010/091/000022
Comparison of NN5401 with insulin glargine, both in combination with oral antidiabetic drugs, in subjects with type 2 diabetes.
CTRI/2007/091/000042
Comparison of two NN1250 formulations versus insulin glargine, all in combination with metformin in subjects with type 2 diabetes
CTRI/2010/091/000241
Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups.
CTRI/2009/091/000636
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients
CTRI/2008/091/000112
Effect of high dose vitamin B1 on early stage kidney disease in type 2 diabetes
CTRI/2008/091/000014
Effect of liraglutide or glimepiride added to metformin on blood glucose control in subjects with type 2 diabetes
CTRI/2009/091/000532
Effect of Naturo fruit bars in type-II diabetes mellitus
CTRI/2010/091/000608
Effect of Passion Fruit Peel extract (PFP) in reducing the CHD risk factor profile in patients with type-2 Diabetes mellitus
CTRI/2009/091/000105
Effects of LY2189265 on Glycemic Control in Patients With Type 2 Diabetes
CTRI/2009/091/000536
Effects of Naturlose (Tagatose) on blood sugar Control and Safety of Naturlose Over One Year in Subjects with Type 2 Diabetes under Diet Control and Exercise
CTRI/2009/091/000126
Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
CTRI/2009/091/000134
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes
CTRI/2009/091/000552
Efficacy and Safety of Alogiptin plus Metformin Compared to Glipizide plus Metformin in Subjects with Type 2 Diabetes Mellitus.
CTRI/2010/091/000253
Efficacy and Safety of Alogliptin Plus Metformin in Subjects With Type 2 Diabetes (AM7D).
CTRI/2011/091/000060
Efficacy and Safety of BI 10773 in Patients With Type 2 Diabetes and Renal Impairment
CTRI/2010/091/001474
Efficacy and Safety of BI 10773 in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
CTRI/2010/091/001212
Efficacy and Safety of BI 10773 With Metformin in Patients With Type 2 Diabetes
CTRI/2010/091/001276
Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus
CTRI/2009/091/000123
Efficacy and Safety Study of Alogliptin Compared to Glipizide in Elderly Diabetics
CTRI/2010/091/001299
Efficacy and Safety Study With BI 10773 vs. Placebo as add-on to Metformin or Metformin Plus Sulfonyurea Over 24 Weeks in Patients With Type 2 Diabetes
CTRI/2010/091/002809
Efficacy of BI 10773 Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
CTRI/2009/091/000217
Evaluate Efficacy and Safety of Saxagliptin in Adult Indian Patients with Type 2 Diabetes inadequate glycemic control.
CTRI/2009/091/000922
EVALUATE THE SAFETY AND EFFICACY OF FIXED DOSE COMBINATION OF METFORMIN HCL 500 mg SR AND VOGLIBOSE 0.2mg IN DIABETIC PATIENTS.
CTRI/2009/091/000560
Evaluation of Safety and Efficacy of Mersina, an Ayurvedic formulation: A double blind, placebo controlled study in type 2 diabetic patients with Secondary failure to Oral drugs
CTRI/2010/091/001186
Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus
CTRI/2010/091/002911
GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients (GLOBE)
CTRI/2010/091/001258
GUARD (GalvUs: A Real WorlD clinical use)
CTRI/2010/091/001386
Insulins Glargine And gluLisine strAtegy vs Premixed insulin strAteGy: a cOmparative Study
CTRI/2009/091/000501
Long-Term Safety Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
CTRI/2009/091/000371
Oral Insulin study for Type 2 Diabetes Mellitus
CTRI/2009/091/000609
Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast
CTRI/2011/091/000093
Premixed Insulin Aspart 30 (Biasp 30) Vs Premixed Human Insulin 30 (Bhi 30)In Gestational Diabetes Mellitus - A Randomised Controlled Study
CTRI/2009/091/000916
Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
CTRI/2009/091/000119
Randomized, db, Placebo-Controlled 18 Week Study of BI 1356 in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
CTRI/2009/091/000484
Safety and Efficacy of Albiglutide in Type 2 Diabetes
CTRI/2008/091/000035
Safety and efficacy of biphasic human insulin compared to EX1000 in type 2 diabetes
CTRI/2010/091/002990
Safety and Efficacy of Galvus (Vildagliptin) as add-on Therapy to Metformin Plus Glimepiride.
CTRI/2009/091/000238
Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
CTRI/2009/091/000203
Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)
CTRI/2009/091/000140
Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease
CTRI/2009/091/000656
Study of an Ayurvedic Formulation Limit for safety and efficacy in type 2 diabetic patients with oral drug failure.
CTRI/2010/091/001170
study of effect of glutathione rich diet in type-2 diabates.
CTRI/2010/091/001073
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
CTRI/2010/091/000390
Study Of Safety And Efficacy Of PF-04971729 In Patients With Type 2 Diabetes.
CTRI/2011/091/000202
Study on the safety and efficacy of BIOCHAPERONE 1 in the treatment of diabetic foot ulcers.
CTRI/2009/091/000479
Study to determine the amount of the study drug (IN-105) absorbed when given as a tablet with breakfast in the morning.
CTRI/2009/091/000546
Study with HO/03/03 in the treatment of Plantar Neuropathic Diabetic Foot Ulcer.
CTRI/2010/091/002814
The COSMID Trial (Comparison of Surgery vs. Medicine for Indian Diabetes).
CTRI/2009/091/000068
The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII Diabetes mellitus
CTRI/2010/091/001361
The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are receving treatment with metformin and pioglitazone and have inadequate glycemic (blood sugar) control
CTRI/2010/091/006067
The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin in patients with type 2 diabetes mellitus who are receiving treatment with metformin and sulphonylurea and have inadequate glycemic (blood sugar) control.
CTRI/2010/091/000410
The study will assess canagliflozin in the treatment of patients with type 2 diabetes mellitus (T2DM) with regard to cardiovascular (CV) risk for major adverse cardiac events. Other objectives include evaluating the overall safety, tolerability, and effectiveness of canagliflozin.
CTRI/2010/091/000056
Thiazolidinedione Intervention With Vitamin D Evaluation (TIDE).
CTRI/2010/091/001337
This is a study to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who have reduced kidney function
CTRI/2008/091/000293
This multi-centered randomized control trial aims to evaluate how lifestyle modification through yoga can influence Type 2 Diabetes
CTRI/2010/091/000595
This study is to demonstrate the efficacy, safety, and tolerability of JNJ-28431754 compared with glimepiride in patients with type 2 diabetes.
CTRI/2010/091/002997
This study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in older patients (55 to 80 years of age) with type 2 diabetes mellitus (T2DM) with inadequate control on their current diabetes treatment regimen.
CTRI/2010/091/002977
This study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin monotherapy (i.e., treatment with a single drug) and have inadequate glycemic (blood sugar) control.
CTRI/2010/091/002824
This study is to evaluate the efficacy, safety, and tolerability of 2 different doses of canagliflozin administered as monotherapy compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise
CTRI/2010/091/000151
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies.
CTRI/2010/091/002938
To compare the effect on blood sugar levels and weight in non-obese type-2 diabetic mellitus patients with BMI 22-35 after Laparoscopic Sleeve gastrectomy, Diverted ileal transposition, Standard ileal transposition & Duodeno-jejunal bypass
CTRI/2008/091/000248
To compare the efficacy and safety of a new formulation of telmisartan with the currently available formulation in the management of patients with type 2 diabetes and hypertension
CTRI/2010/091/001244
To see the effect of polyherbal formulation in diabetes patients
CTRI/2010/091/000580
To Study the effect, safety, and tolerability of every 4 weekly administration of subcutaneous Mircera for treating renal anaemia in diabetic nephropathy patients
CTRI/2009/091/000563
Trial to Evaluate Cardiovascular Outcomes with Sitagliptin
CTRI/2008/091/000201
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes